(Q35202202)

7 August 2017

1 reference

title

Review article: the role of rebamipide in the management of inflammatory disease of the gastrointestinal tract (English)

1 reference

7 August 2017

1 reference

R M Genta

1

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

Alimentary Pharmacology & Therapeutics

7 August 2017

published in

1 reference

7 August 2017

volume

18 Suppl 1

1 reference

7 August 2017

page(s)

8-13

1 reference

Epidemiology of Helicobacter pylori and gastric cancer

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.18.S1.5.X

Double-blind placebo-controlled multicentre studies of rebamipide, a gastroprotective drug, in the treatment of functional dyspepsia with or without Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.18.S1.5.X

A short-term eradication therapy for Helicobacter pylori acute gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.18.S1.5.X

Long-term rebamipide therapy improves Helicobacter pylori-associated chronic gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.18.S1.5.X

Combined effect of rebamipide and ecabet sodium on Helicobacter pylori adhesion to gastric epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.18.S1.5.X

The antioxidant effect of rebamipide on oxygen free radical production by H. pylori-activated human neutrophils: in comparison with N-acetylcysteine, ascorbic acid and glutathione

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.18.S1.5.X

OPC-compounds prevent oxidant-induced carbonylation and depolymerization of the F-actin cytoskeleton and intestinal barrier hyperpermeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.18.S1.5.X

Alterations of epithelial permeability by Helicobacter and IL-1beta in vitro: protective effect of rebamipide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.18.S1.5.X

10.1046/J.1365-2036.18.S1.5.X

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference